High-Phosphate-Induced Hypertension: The Pathogenic Role of Fibroblast Growth Factor 23 (FGF23) Signaling in Sympathetic Nervous System Activation
International Journal of Molecular Sciences · 23.01.2026 · 27 (3) · 1138
DOI: 10.3390/ijms27031138 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.01.2026. Verfasst von Han-Kyul Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine-Cardiology Division-Hypertension Section, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Hypertension, Sympathetic Nervous System, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, American Heart Association, the Cardiology Division startup.
Abstract (Originalsprache)
Hypertension remains a major public health concern globally. Accumulating evidence suggests that dietary phosphate (Pi) and fibroblast growth factor 23 (FGF23), a phosphaturic hormone, are involved in blood pressure regulation. Experimental studies have shown that excess Pi consumption, largely from inorganic Pi used as a preservative or flavor enhancer in processed foods, and increased FGF23 may contribute to vascular abnormalities, thereby promoting hypertension. Importantly, recent animal studies have demonstrated that peripheral FGF23 can cross the blood–brain barrier and stimulate FGF receptor 4 (FGFR4)-calcineurin signaling in the brain, contributing to sympathetic overactivation and hypertensive responses during high Pi loading. Additionally, dietary Pi loading leads to suppression of Klotho, which may further contribute to hypertension. Such mechanisms are potentially relevant to chronic kidney disease (CKD), a condition characterized by Pi retention, massively elevated FGF23, sympathetic overactivity, and hypertension. This review highlights current evidence linking Pi-induced FGF23 pathogenically to hypertension, with focus on FGF23 translocation to and FGFR4 signaling in the central nervous system as a potential mechanism and therapeutic target for hypertension associated with high Pi intake and CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine-Cardiology Division-Hypertension Section, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Internal Medicine-Nephrology Division, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Han-Kyul Kim
Förderung
- NIDDK NIH HHS
- American Heart Association
- the Cardiology Division startup
- the Charles and Jane Pak Center for Mineral Metabolism and Clinical Research
- National Institutes of Health National Heart, Lung, and Blood Institute
- Cardiology Division startup and the Pak Center Endowed Professor Collaborative Support Grant at UT Southwestern Medical Center
Zitieren
APA
Kim, H. K., Moe, O. W., & Vongpatanasin, W. (2026). High-Phosphate-Induced Hypertension: The Pathogenic Role of Fibroblast Growth Factor 23 (FGF23) Signaling in Sympathetic Nervous System Activation. International Journal of Molecular Sciences, 27(3), 1138. https://doi.org/10.3390/ijms27031138
Vancouver
Kim HK, Moe OW, Vongpatanasin W. High-Phosphate-Induced Hypertension: The Pathogenic Role of Fibroblast Growth Factor 23 (FGF23) Signaling in Sympathetic Nervous System Activation. International Journal of Molecular Sciences. 2026;27(3):1138. doi:10.3390/ijms27031138
BibTeX
@article{Kim2026,
author = {Kim, Han-Kyul and Moe, Orson W and Vongpatanasin, Wanpen},
title = {High-Phosphate-Induced Hypertension: The Pathogenic Role of Fibroblast Growth Factor 23 (FGF23) Signaling in Sympathetic Nervous System Activation},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {3},
pages = {1138},
doi = {10.3390/ijms27031138}
}
EUVIMED